Trader Note — 11151 total
Danaher heads into its October 20 earnings date with a stock recovering cleanly but insider activity at the C-suite level still worth parsing. The recovery is real. The stock gained 3% on Tuesday alone, closing at…
D.R. Horton enters the final stretch of its fiscal year with a telling gap between where analysts say the stock is worth and where the market has pushed it — two firms cut targets this week alone, even as shares hold…
COST heads into its September 24 earnings print with the stock down nearly 7% over the past month, a freshly trimmed target from a bellwether firm, and the put/call ratio ticking back up from last week's neutral…
CMCSA enters the week before its October 22 earnings with a bruising 7.3% weekly decline to $24.42, fresh analyst target cuts from BofA and UBS, and a stock that now trades well below every major price target on the…
KO enters the week before October earnings with an unusual wrinkle: the stock is up on the month, short sellers have turned mildly more active, and yet options traders have abruptly swung toward the most defensive…
Citigroup heads into its October 13 Q1 results with short sellers pulling back meaningfully, the stock drifting lower, and options traders running with a structurally defensive tilt that has barely budged all…
Cintas enters its September 23 earnings print with a quietly charged setup: short interest has jumped nearly 11% in a single week, options positioning has tilted more defensive than it has been in months, and the stock…
CIEN enters the post-earnings period in an awkward spot: the stock has shed 22% in a month yet bounced 4.6% on Tuesday, with analysts cutting targets across the board but refusing to pull their buy ratings. The…
Churchill Downs enters the final stretch before its October 28 earnings print with short sellers building positions at their fastest weekly pace in months, even as the stock slides to its lowest levels since early…
Chevron closed Tuesday at $217.77, up another 3.8% on the week, yet the most pointed shift in this week's data is not the price — it is a quiet but clear move toward caution in the options market, arriving just as the…
Carnival Corporation heads into its September 25 earnings report with short sellers rebuilding positions at the fastest pace in months, even as the Street holds broadly bullish ratings and analysts trim targets across…
CCO heads into the week of September 16 having shed nearly 10% in five trading sessions, part of a broad uranium-sector pullback that is compressing a rich valuation and sharpening the question of whether the premium…
CAE heads into mid-September with a stock down 9% over the past month and short sellers quietly adding to positions — a steady creep rather than a dramatic repositioning, but one that stands out given the company's…
Bruker Corporation closed Tuesday at $55.75, up nearly 6% on the day but still 4.5% lower on the week — a divergence that stands out when most of its peer group finished the week solidly higher. The most interesting…
Brown & Brown heads into its October 26 earnings window with short sellers slowly returning after a sharp capitulation, while the Street debates whether the stock's 5% one-month slide has created a genuine entry point…
Options traders at BMY are flashing their most defensive posture in weeks, just as short sellers quietly cover — and a fresh analyst upgrade adds a layer of conviction to the bull case. The most striking move this week…
Brinker International heads into its Wednesday earnings print having shed 8.5% in the past five trading days, yet with one telling divergence: the short sellers who once crowded into this trade are quietly reducing…
BYD enters the week before its October 22 earnings date with a sharp and sudden rebuild in bearish positioning — short interest has risen 32% in seven days, the ORTEX short score has climbed nearly 12 points in a week,…
BA at $209.69 enters the final stretch before its October 21 earnings call carrying a curious split: analyst sentiment is the most constructive it has been in years, yet the stock has shed nearly 10% over the past…
Bausch Health Companies enters the week after one of its worst monthly stretches in recent memory, with the stock off nearly 13% in a month and the options market deeply skewed toward downside protection — yet the…
